Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Fischer

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 1, 2022
Distribution of a highly lipophilic drug cannabidiol into different lymph nodes following oral administration in lipidic vehicleAdelaide Jewell, Alice Brookes, Wanshan Feng, et al.
Oncotarget|February 6, 2014
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabineElisabeth Walsby, Guy Pratt, Hao Shao, et al.
Journal of Medicinal Chemistry|April 15, 2011
Immunosuppressive but non-LasR-inducing analogues of the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-l-homoserine lactoneGopal P Jadhav, Siri Ram Chhabra, Gary Telford, et al.
European Journal of Medicinal Chemistry|February 13, 2021
Structure-based design of highly selective 2,4,5-trisubstituted pyrimidine CDK9 inhibitors as anti-cancer agentsHao Shao, David W Foley, Shiliang Huang, et al.
Journal of Medicinal Chemistry|December 21, 2012
Comparative structural and functional studies of 4-(thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 inhibitors suggest the basis for isotype selectivityAlison J Hole, Sonja Baumli, Hao Shao, et al.
Biomedical Chromatography : BMC|June 30, 2020
Development and validation of a cost-effective and sensitive bioanalytical HPLC-UV method for determination of lopinavir in rat and human plasmaChaolong Qin, Wanshan Feng, YenJu Chu, et al.
Thrombosis and Haemostasis|February 19, 2002
A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formationLars Orning, Peter M Fischer, Chih-Kao Hu, et al.
Chemistry & Biology|February 24, 2006
Differential binding of inhibitors to active and inactive CDK2 provides insights for drug designGeorge Kontopidis, Campbell McInnes, Sravan R Pandalaneni, et al.
Nature Chemical Biology|October 10, 2006
Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenanceCampbell McInnes, Aveek Mazumdar, Mokdad Mezna, et al.
European Journal of Medicinal Chemistry|November 5, 2013
Synthesis, structure-activity relationship and biological evaluation of 2,4,5-trisubstituted pyrimidine CDK inhibitors as potential anti-tumour agentsHao Shao, Shenhua Shi, David W Foley, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 1, 2022
Distribution of a highly lipophilic drug cannabidiol into different lymph nodes following oral administration in lipidic vehicleAdelaide Jewell, Alice Brookes, Wanshan Feng, et al.
Oncotarget|February 6, 2014
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabineElisabeth Walsby, Guy Pratt, Hao Shao, et al.
Journal of Medicinal Chemistry|April 15, 2011
Immunosuppressive but non-LasR-inducing analogues of the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-l-homoserine lactoneGopal P Jadhav, Siri Ram Chhabra, Gary Telford, et al.
European Journal of Medicinal Chemistry|February 13, 2021
Structure-based design of highly selective 2,4,5-trisubstituted pyrimidine CDK9 inhibitors as anti-cancer agentsHao Shao, David W Foley, Shiliang Huang, et al.
Journal of Medicinal Chemistry|December 21, 2012
Comparative structural and functional studies of 4-(thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 inhibitors suggest the basis for isotype selectivityAlison J Hole, Sonja Baumli, Hao Shao, et al.
Biomedical Chromatography : BMC|June 30, 2020
Development and validation of a cost-effective and sensitive bioanalytical HPLC-UV method for determination of lopinavir in rat and human plasmaChaolong Qin, Wanshan Feng, YenJu Chu, et al.
Thrombosis and Haemostasis|February 19, 2002
A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formationLars Orning, Peter M Fischer, Chih-Kao Hu, et al.
Chemistry & Biology|February 24, 2006
Differential binding of inhibitors to active and inactive CDK2 provides insights for drug designGeorge Kontopidis, Campbell McInnes, Sravan R Pandalaneni, et al.
Nature Chemical Biology|October 10, 2006
Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenanceCampbell McInnes, Aveek Mazumdar, Mokdad Mezna, et al.
European Journal of Medicinal Chemistry|November 5, 2013
Synthesis, structure-activity relationship and biological evaluation of 2,4,5-trisubstituted pyrimidine CDK inhibitors as potential anti-tumour agentsHao Shao, Shenhua Shi, David W Foley, et al.
Pageof 12